Identity
- Trade Name
- PR 4100 FDA UDI
- Generic Name
- Enzyme immunoassay (EIA) analyser IVD FDA UDI
- Device Name
- PR 4100 FDA UDI
- Model / Reference
- 91587 FDA UDI
- Description
- PR 4100 FDA UDI
Identifiers
- Catalog Number
- 91587 FDA UDI
- Primary DI / UDI-DI
- 03610520013571 FDA UDI
- FDA Product Code
- JJQ FDA UDI
- GMDN Term
- Enzyme immunoassay (EIA) analyser IVD FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 862.2300 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Enzyme immunoassay (EIA) analyser IVD
Pr 4100 by Bio-Rad — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Enzyme immunoassay (EIA) analyser IVD.
- ORTHO — Ortho-Clinical Diagnostics · N
- EUROLabWorkstation ELISA — EUROIMMUN Medizinische Labordiagnostika AG · Class I
- ORTHO — Ortho-Clinical Diagnostics · N
- ThunderBolt EIA (CLIA) — Gold Standard Diagnostics, LLC · Class I
- CHORUS TRIO — DIESSE DIAGNOSTICA SENESE SPA · Class I
- ORTHO — Ortho-Clinical Diagnostics · N
- Bolt (CLIA) — Gold Standard Diagnostics, LLC · Class I
- UNION Immune Analyzer — Shenzhen YHLO Biotech Co., Ltd. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Bio-Rad
Sources (1)
- FDA UDI 9f45c7a0-5dab-4947-97da-25c6685dd4b2 37 fields · synced Jun 8, 2026